ClinicalTrials.Veeva

Menu

CPAP, Nutrition & Exercise Against Sleep Apnea (TINE)

R

Raphael Heinzer

Status

Unknown

Conditions

Overweight and Obesity
Sleep Apnea

Treatments

Other: Tailored intervention
Other: Control

Study type

Interventional

Funder types

Other

Identifiers

NCT03959280
2019-00586

Details and patient eligibility

About

This study evaluates the addition of a comprehensive lifestyle program including dietary management and exercise to continuous positive airway pressure (CPAP) therapy in overweighted adults with obstructive sleep apnea. Half of the participants will receive CPAP therapy while the other half will have diet consultations, nordic walking sessions and CPAP.

Full description

While the specific impact of obstructive sleep apnea (OSA) on quality of life is well established, the impact of CPAP therapy on quality of life remains unclear. Yet, improving the quality of life of OSA patient is one of the main targets of treatment.

Both exercise and healthy diet are recommended in the management of overweight and obesity. This should improve quality of life as well as comorbidities associated with sleep apnea.

Enrollment

120 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients newly diagnosed for obstructive sleep apnea and requiring CPAP therapy
  • BMI>25and≤40kg/m2
  • Low physical activity (< 150 min of MVPA per week)
  • IAH≥15
  • Able to give informed consent as documented by signature

Exclusion criteria

  • Patients already treated for OSA or another sleep disorder
  • Required use of supplemental oxygen
  • Active infection, malignancy or chronic inflammatory disorders
  • More than moderate alcohol use of > 14 drinks per week
  • Severe depression defined by a BDI > 30
  • Surgery within the previous 3 months
  • Known cardiac or pulmonary disease contraindicating exercise training
  • Patient with a bariatric surgery project or already operated
  • Pregnant or lactating women
  • Onset of a severe cardiac disease contraindicating exercise training
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, peripheral functional limitation.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

120 participants in 2 patient groups

Tailored intervention
Experimental group
Description:
In this group, participants will receive a comprehensive lifestyle program in addition to CPAP therapy which will include a supervised exercise program, diet interventions and behavioural counselling during 12 weeks. Then, participants will follow a real-world maintenance program from weeks 12 to 24. It will include one telephone-based contact per month with the study coordinator. Participants will be encouraged to maintain their lifestyle modification during this phase.
Treatment:
Other: Tailored intervention
Control
Active Comparator group
Description:
Participant in this group will benefit from routine CPAP therapy management from week 0 to 24.
Treatment:
Other: Control

Trial contacts and locations

2

Loading...

Central trial contact

Mathieu Berger, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems